FUM — Futura Medical Share News
0.000.00%
- £3.84m
- £2.60m
- £1.70m
Holding(s) in Company
TR-1: Notification of major holdings
Encouraging New Product Development Pipeline
Clinical trial data presented at SMSNA
Further milestone payment triggered post US launch
Directors’ / PDMR Dealing
Brief: Futura Medical Sees 2024 Revenue At £13.4 Mln
Trinity Delta research note & consensus forecasts
Futura Medical - Interim Results 2024
Update on US launch
Notice of Results
Brief: Futura Medical Says Trading In Line With Market View For FY2024
Update on US launch
Revenues Remain In Line With Market Expectations For Fy2024
AGM Statement
Notice of AGM and availability of Annual Report
Brief: Futura Medical Expects 2024 To Be Year Of Precise Execution With Further Commercialisation Of Eroxon
Results for the Year ended 31 December 2023
Notice of Results and Investor Presentation